These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1379843)

  • 21. Protein kinase CK2alpha is a target for the Abl and Bcr-Abl tyrosine kinases.
    Hériché JK; Chambaz EM
    Oncogene; 1998 Jul; 17(1):13-8. PubMed ID: 9671309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine phosphorylated proteins in chronic myelogenous leukemia.
    Frackelton AR; Kumar PS; Kannan B; Clark JW
    Leuk Lymphoma; 1993; 11 Suppl 1():125-9. PubMed ID: 7504542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues.
    Huhn RD; Posner MR; Rayter SI; Foulkes JG; Frackelton AR
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4408-12. PubMed ID: 2440021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells.
    Naldini L; Stacchini A; Cirillo DM; Aglietta M; Gavosto F; Comoglio PM
    Mol Cell Biol; 1986 May; 6(5):1803-11. PubMed ID: 2431286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.
    Freed E; Hunter T
    Mol Cell Biol; 1992 Mar; 12(3):1312-23. PubMed ID: 1545812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.
    de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
    J Biol Chem; 1995 Sep; 270(37):21468-71. PubMed ID: 7545163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl.
    Salgia R; Sattler M; Pisick E; Li JL; Griffin JD
    Exp Hematol; 1996 Feb; 24(2):310-3. PubMed ID: 8641358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl.
    de Jong R; van Wijk A; Haataja L; Heisterkamp N; Groffen J
    J Biol Chem; 1997 Dec; 272(51):32649-55. PubMed ID: 9405482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity.
    Kashige N; Carpino N; Kobayashi R
    Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2093-8. PubMed ID: 10688886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells.
    Carpino N; Wisniewski D; Strife A; Marshak D; Kobayashi R; Stillman B; Clarkson B
    Cell; 1997 Jan; 88(2):197-204. PubMed ID: 9008160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of biosynthesis and phosphorylation of P210bcr/abl protein during differentiation induction of K 562 cells.
    Nishimura J; Takahira H; Shibata K; Muta K; Yamamoto M; Ideguchi H; Umemura T; Nawata H
    Leuk Res; 1988; 12(11-12):875-85. PubMed ID: 2464113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine protein kinase substrates in Philadelphia-positive human chronic granulocytic leukemia derived cell lines (K562 and BV173): detection by using an immunoblotting technique.
    Evans JP; Wickremasinghe RG; Hoffbrand AV
    Leukemia; 1987 Jun; 1(6):524-5. PubMed ID: 2444834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction in protein tyrosine phosphorylation during differentiation of human leukemia cell line K-562.
    Richardson JM; Morla AO; Wang JY
    Cancer Res; 1987 Aug; 47(15):4066-70. PubMed ID: 2440557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines.
    Druker B; Okuda K; Matulonis U; Salgia R; Roberts T; Griffin JD
    Blood; 1992 May; 79(9):2215-20. PubMed ID: 1571536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of herbimycin A, an inhibitor of tyrosine kinase, on protein tyrosine kinase activity and phosphotyrosyl proteins of Ph1-positive leukemia cells.
    Okabe M; Kawamura K; Miyagishima T; Itaya T; Goodwyn D; Shoji M; Vogler WR; Sakurada K; Uehara M; Miyazaki T
    Leuk Res; 1994 Mar; 18(3):213-20. PubMed ID: 7511193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia.
    Oda T; Heaney C; Hagopian JR; Okuda K; Griffin JD; Druker BJ
    J Biol Chem; 1994 Sep; 269(37):22925-8. PubMed ID: 8083188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered physical state of p210bcr-abl in tyrphostin AG957-treated K562 cells.
    Kaur G; Sausville EA
    Anticancer Drugs; 1996 Nov; 7(8):815-24. PubMed ID: 8991184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of BCR-ABL with the retinoblastoma protein in Philadelphia chromosome-positive cell lines.
    Miyamura T; Nishimura J; Yufu Y; Nawata H
    Int J Hematol; 1997 Feb; 65(2):115-21. PubMed ID: 9071815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of downstream effectors of BCR/ABL protein tyrosine kinase using combined proteomic approaches.
    Lee CF; Griffiths S; Rodríguez-Suárez E; Pierce A; Unwin RD; Jaworska E; Evans CA; J Gaskell S; Whetton AD
    Proteomics; 2010 Sep; 10(18):3321-42. PubMed ID: 20706980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of protein-tyrosine kinase activity in intact cells by the aptameric action of oligodeoxynucleotides.
    Bergan RC; Kyle E; Connell Y; Neckers L
    Antisense Res Dev; 1995; 5(1):33-8. PubMed ID: 7542047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.